Loading clinical trials...
Loading clinical trials...
This was a multicenter, randomized, double-blind, placebo-parallel-controlled Phase II clinical study to evaluate the efficacy and safety of HRS9531 Injection compared to placebo in obese subjects wit...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
NCT07083011 · Heart Failure With Preserved Ejection Fraction
NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more
NCT07057466 · Valvular Heart Disease Stenosis and Regurgitation (Diagnosis), Pulmonary Hypertension (Diagnosis), and more
NCT07093528 · Heart Failure With Preserved Ejection Fraction, Coronary Microvascular Dysfunction
NCT07219511 · Heart, Heart Failure With Preserved Ejection Fraction (HFPEF)
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions